People don’t come to work every day to make money for shareholders, observes Vir Biotechnology president and CEO George Scangos. In biotech, he finds, most teams are instead motivated by the prospect of improving peoples’ lives. Consequently, he argues, his role as CEO is not to focus exclusively on maximizing shareholder returns, but to also think about responsibilities to other stakeholders, including patients, employees, the community and the environment.
Related

Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.
Video
53 minutes
Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.

Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Video
54 minutes
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.

Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
Video
58 minutes
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.